Zobrazeno 1 - 10
of 409
pro vyhledávání: '"JEAN L. ROULEAU"'
Autor:
Natasha L. Patel‐Murray, Luqing Zhang, Brian L. Claggett, Dongchu Xu, Pablo Serrano‐Fernandez, Margaret Healey, Simon Wandel, Chien‐Wei Chen, Jaison Jacob, Huilei Xu, Gordon M. Turner, William Chutkow, Denise P. Yates, Christopher J. O'Donnell, Margaret F. Prescott, Martin Lefkowitz, Claudio R. Gimpelewicz, Michael T. Beste, Faye Zhao, Liangke Gou, Akshay S. Desai, Pardeep S. Jhund, Milton Packer, Marc A. Pfeffer, Margaret M. Redfield, Jean L. Rouleau, Faiez Zannad, Michael R. Zile, John J. V. McMurray, Michael M. Mendelson, Scott D. Solomon, Jonathan W. Cunningham
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 13 (2024)
Background Prognostic markers and biological pathways linked to detrimental clinical outcomes in heart failure with preserved ejection fraction (HFpEF) remain incompletely defined. Methods and Results We measured serum levels of 4123 unique proteins
Externí odkaz:
https://doaj.org/article/e39880796038474e881ba373a0b6c360
Autor:
Jawad H. Butt, Kirsty McDowell, Toru Kondo, Akshay S. Desai, Martin P. Lefkowitz, Milton Packer, Mark C. Petrie, Marc A. Pfeffer, Jean L. Rouleau, Muthiah Vaduganathan, Michael R. Zile, Pardeep S. Jhund, Lars Køber, Scott Solomon, John J.V. McMurray
Publikováno v:
ESC Heart Failure, Vol 11, Iss 1, Pp 65-77 (2024)
Abstract Aims Red cell distribution width (RDW) is a strong prognostic marker in patients with heart failure (HF) and reduced ejection fraction and other conditions. However, very little is known about its prognostic significance in HF with preserved
Externí odkaz:
https://doaj.org/article/cc3942df190d4a5ebb48c652a5cce4f4
Autor:
Elmir Omerovic, Mark Petrie, Björn Redfors, Stephen Fremes, Gavin Murphy, Guillaume Marquis-Gravel, Alexandra Lansky, Eric Velazquez, Divaka Perera, Christopher Reid, Julian Smith, Peter van der Meer, Eric Lipsic, Peter Juni, John McMurray, Johann Bauersachs, Lars Køber, Jean L. Rouleau, Torsten Doenst
Publikováno v:
Trials, Vol 25, Iss 1, Pp 1-13 (2024)
Abstract In an era focused on value-based healthcare, the quality of healthcare and resource allocation should be underpinned by empirical evidence. Pragmatic clinical trials (pRCTs) are essential in this endeavor, providing randomized controlled tri
Externí odkaz:
https://doaj.org/article/24d79e7c4c284da99308af6fa57f3145
Autor:
Corrado De Marco, Brian L. Claggett, Simon deDenus, Michael R. Zile, Thao Huynh, Akshay S. Desai, Martin G. Sirois, Scott D. Solomon, Bertram Pitt, Jean L. Rouleau, Marc A. Pfeffer, Eileen O'Meara
Publikováno v:
ESC Heart Failure, Vol 8, Iss 2, Pp 1130-1138 (2021)
Abstract Aims Diabetes mellitus (DM) is common in heart failure with preserved ejection fraction (HFpEF). Patients with DM and heart failure with reduced ejection fraction have higher levels of cardiac, profibrotic, and proinflammatory biomarkers rel
Externí odkaz:
https://doaj.org/article/b070388439fb4ff99e7b2abea15e1756
Autor:
Su E. Yeoh, Pooja Dewan, Akshay S. Desai, Scott D. Solomon, Jean L. Rouleau, Marty Lefkowitz, Adel Rizkala, Karl Swedberg, Michael R. Zile, Pardeep S. Jhund, Milton Packer, John J.V. McMurray
Publikováno v:
ESC Heart Failure, Vol 7, Iss 6, Pp 3355-3364 (2020)
Abstract Aims Little is known about patient characteristics, outcomes, and the effect of treatment in relation to duration of heart failure (HF). We have investigated these questions in PARADIGM‐HF. The aim of the study was to compare patient chara
Externí odkaz:
https://doaj.org/article/6b9cd33b5f4844ebbfd23120209dea3b
Autor:
Amand F. Schmidt, Saskia Haitjema, Ulrik Sartipy, Martin J. Holzmann, David J. Malenka, Cathy S. Ross, Wiek van Gilst, Jean L. Rouleau, Annelijn M. Meeder, Robert A. Baker, Hiroki Shiomi, Takeshi Kimura, Lavinia Tran, Julian A. Smith, Christopher M. Reid, Folkert W. Asselbergs, Hester M. den Ruijter
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
ObjectivesWomen have a worse prognosis after coronary artery bypass grafting (CABG) surgery compared to men. We sought to quantify to what extent this difference in post-CABG survival could be attributed to sex itself, or whether this was mediated by
Externí odkaz:
https://doaj.org/article/f4e4a81237ca4ee7969687ca8d429ad9
Autor:
Nadia Bouabdallaoui, MD, William Beaubien-Souligny, MD, Essaïd Oussaïd, MSc, Christine Henri, MD, Normand Racine, MD, André Y. Denault, MD, PhD, Jean L. Rouleau, MD
Publikováno v:
CJC Open, Vol 2, Iss 5, Pp 311-320 (2020)
Background: The Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST) score has proven useful for risk prediction in acute decompensated heart failure (ADHF). However, this score does not include the characteriza
Externí odkaz:
https://doaj.org/article/9c284bf739ca4032bfb319c7196e1a01
Publikováno v:
ESC Heart Failure, Vol 7, Iss 4, Pp 1723-1734 (2020)
Abstract Aims Venous congestion is a major determinant of worsening renal function (WRF) in acute decompensated heart failure (ADHF), particularly when associated with right ventricular (RV) dysfunction. Whether the individual impacts of hemodynamic
Externí odkaz:
https://doaj.org/article/f30f87df74294649988893599b95ee10
Autor:
Leanne Mooney, Nathaniel M. Hawkins, Pardeep S. Jhund, Margaret M. Redfield, Muthiah Vaduganathan, Akshay S. Desai, Jean L. Rouleau, Masatoshi Minamisawa, Amil M. Shah, Martin P. Lefkowitz, Michael R. Zile, Dirk J. Van Veldhuisen, Marc A. Pfeffer, Inder S. Anand, Aldo P. Maggioni, Michele Senni, Brian L. Claggett, Scott D. Solomon, John J. V. McMurray
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 23 (2021)
Background Little is known about the impact of chronic obstructive pulmonary disease (COPD) in patients with heart failure with preserved ejection fraction (HFpEF). Methods and Results We examined outcomes in patients with heart failure with preserve
Externí odkaz:
https://doaj.org/article/88441a2adc5146caaed5c0a4cbd5ced4
Autor:
Solmaz Ehteshami‐Afshar, Leanne Mooney, Pooja Dewan, Akshay S. Desai, Ninian N. Lang, Martin P. Lefkowitz, Mark C. Petrie, Adel R. Rizkala, Jean L. Rouleau, Scott D. Solomon, Karl Swedberg, Victor C. Shi, Michael R. Zile, Milton Packer, John J. V. McMurray, Pardeep S. Jhund, Nathaniel M. Hawkins
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 4 (2021)
Background Chronic obstructive pulmonary disease (COPD) is a common comorbidity in heart failure with reduced ejection fraction, associated with undertreatment and worse outcomes. New treatments for heart failure with reduced ejection fraction may be
Externí odkaz:
https://doaj.org/article/f1947c06aea54dc6810c12c87aac40a8